Shopping Cart
- Remove All
- Your shopping cart is currently empty
Remogliflozin etabonate (GSK189075A) is a prodrug of regaliflozin and an inhibitor SGLT2 with Ki values of 1.95, 2.14, 8.57, and 43.1μM for hSGLT2, rSGLT2, rSGLT1, and hSGLT1, respectively.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $30 | In Stock | |
5 mg | $48 | In Stock | |
10 mg | $88 | In Stock | |
25 mg | $167 | In Stock | |
50 mg | $257 | In Stock | |
100 mg | $358 | In Stock | |
200 mg | $497 | In Stock | |
1 mL x 10 mM (in DMSO) | $56 | In Stock |
Description | Remogliflozin etabonate (GSK189075A) is a prodrug of regaliflozin and an inhibitor SGLT2 with Ki values of 1.95, 2.14, 8.57, and 43.1μM for hSGLT2, rSGLT2, rSGLT1, and hSGLT1, respectively. |
Targets&IC50 | SGLT2 (rat):2.14 μM (Ki), SGLT1 (rat):8.57 μM (Ki), SGLT1 (human):43.1 μM (Ki), SGLT2 (human):1.95 μM (Ki) |
In vivo | Oral administration of Remogliflozin etabonate (10-30 mg/kg) dose-dependently reduces the levels of FPG and GHb. Oral administration of Remogliflozin etabonate (3-30 mg/kg) dose-dependently increases urine volume and urinary glucose excretion[2]. |
Alias | GSK-189075A, GSK189075A, GSK-189075, GSK189075, GSK 189075A, GSK 189075 |
Molecular Weight | 522.59 |
Formula | C26H38N2O9 |
Cas No. | 442201-24-3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 90.0 mg/mL (172.2 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.